Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Nutrients ; 13(1)2021 Jan 16.
Artigo em Inglês | MEDLINE | ID: mdl-33467050

RESUMO

Using a predetermined set of criteria, including burden of anemia and neural tube defects (NTDs) and an enabling environment for large-scale fortification, this paper identifies 18 low- and middle-income countries with the highest and most immediate potential for large-scale wheat flour and/or rice fortification in terms of health impact and economic benefit. Adequately fortified staples, delivered at estimated coverage rates in these countries, have the potential to avert 72.1 million cases of anemia among non-pregnant women of reproductive age; 51,636 live births associated with folic acid-preventable NTDs (i.e., spina bifida, anencephaly); and 46,378 child deaths associated with NTDs annually. This equates to a 34% reduction in the number of cases of anemia and 38% reduction in the number of NTDs in the 18 countries identified. An estimated 5.4 million disability-adjusted life years (DALYs) could be averted annually, and an economic value of 31.8 billion United States dollars (USD) generated from 1 year of fortification at scale in women and children beneficiaries. This paper presents a missed opportunity and warrants an urgent call to action for the countries identified to potentially avert a significant number of preventable birth defects, anemia, and under-five child mortality and move closer to achieving health equity by 2030 for the Sustainable Development Goals.


Assuntos
Anemia/economia , Anemia/prevenção & controle , Anormalidades Congênitas/economia , Anormalidades Congênitas/prevenção & controle , Efeitos Psicossociais da Doença , Análise Custo-Benefício/economia , Países em Desenvolvimento/economia , Farinha , Alimentos Fortificados , Política de Saúde , Renda , Defeitos do Tubo Neural/economia , Defeitos do Tubo Neural/prevenção & controle , Oryza , Criança , Mortalidade da Criança , Feminino , Humanos , Desenvolvimento Sustentável
2.
Klin Padiatr ; 228(4): 195-201, 2016 Jul.
Artigo em Alemão | MEDLINE | ID: mdl-27043080

RESUMO

BACKGROUND: Marked progress in neonatology changed care of very preterm infants (VLBW) over the last decades - but also the attitude towards family-centred care (FCC). With the directive of the German Federal Joined Committee (G-BA), politicians recognize the necessity of neonatal FCC. AIM: To evaluate time and personnel costs necessary at a centre of established FCC. METHODS: Elternberatung "Frühstart" is a FCC programme for VLBW and seriously ill neonates from preganancy at risk to follow-up home-visits delivered by one interdisciplinary team. Analysis (2011-2014): 1.) Number of cases /participation in programme, 2.) resources of time, 3) and personnel, 4.) funding, 5) economic impact. RESULTS: 1.1.2011-31.12.2014: 441 cases (total cases: 2 212) participated in the programme. Participation of VLBW: mean 92% (86.4-97,2%). Costs of time are highest in neonates with congenital malformations: median 13.8 h, VLBW: median 11,2 h. Transition to home is most time intensive: median 7,3 (0-42.5) h. In average of 3.1 full-time nurses (part-time workers) are able to counsel 48 families/quarter. In severe cases funding is partly provided by health care insurances for social medical aftercare: positive applications: mean 92.7% (79.6-97.7%). CONCLUSION: Participation in the FCC programme in neonatology is high and costs of time are manageable.


Assuntos
Anormalidades Congênitas/economia , Anormalidades Congênitas/enfermagem , Enfermagem Familiar/economia , Custos de Cuidados de Saúde/estatística & dados numéricos , Visita Domiciliar/economia , Doenças do Prematuro/economia , Doenças do Prematuro/enfermagem , Recém-Nascido de muito Baixo Peso , Anormalidades Congênitas/epidemiologia , Análise Custo-Benefício/estatística & dados numéricos , Educação não Profissionalizante/economia , Educação não Profissionalizante/estatística & dados numéricos , Enfermagem Familiar/estatística & dados numéricos , Feminino , Alemanha , Recursos em Saúde/economia , Recursos em Saúde/estatística & dados numéricos , Visita Domiciliar/estatística & dados numéricos , Humanos , Recém-Nascido , Doenças do Prematuro/epidemiologia , Comunicação Interdisciplinar , Colaboração Intersetorial , Masculino , Programas Nacionais de Saúde/economia , Programas Nacionais de Saúde/estatística & dados numéricos
3.
Chirurg ; 80(12): 1099-105, 2009 Dec.
Artigo em Alemão | MEDLINE | ID: mdl-19921499

RESUMO

Pediatric surgery focuses not on an anatomic region or organ system, but on the development of a growing human being according to age. Recently, a tendency to reduce and to downgrade pediatric surgery could be observed which is due to economic reasons and an alarming lack of trained surgeons. Just as 60 years ago, general surgeons continue to operate on infants and children. However, this is a step backwards and an anachronism. Children are not small adults and pediatric surgery can be distinguished from adult surgery in many aspects, such as the spectrum of surgical diseases, the congenital malformations and frequently the indications and techniques of surgery. Pediatric surgeons, however, by themselves should specialize in centers which are focused on rare and complex diseases. Pediatric surgery should not be separated in the hospital, but integrated in a network with general surgery, traumatology, pediatrics, neonatology and specialists of the other surgical disciplines. Strict patient age limitations are not compatible with the individuality of adolescents and should be avoided. A well-equipped clinic for pediatric surgery is expensive, but a mandatory investment in the future!


Assuntos
Pediatria/tendências , Especialidades Cirúrgicas/tendências , Criança , Pré-Escolar , Anormalidades Congênitas/economia , Anormalidades Congênitas/cirurgia , Análise Custo-Benefício/tendências , Prestação Integrada de Cuidados de Saúde/economia , Prestação Integrada de Cuidados de Saúde/tendências , Previsões , Alemanha , Acessibilidade aos Serviços de Saúde/economia , Acessibilidade aos Serviços de Saúde/tendências , Humanos , Lactente , Recém-Nascido , Doenças do Prematuro/economia , Doenças do Prematuro/cirurgia , Programas Nacionais de Saúde/economia , Equipe de Assistência ao Paciente/economia , Equipe de Assistência ao Paciente/tendências , Pediatria/economia , Garantia da Qualidade dos Cuidados de Saúde/economia , Garantia da Qualidade dos Cuidados de Saúde/tendências , Especialidades Cirúrgicas/economia
4.
Matern Child Health J ; 10(5 Suppl): S93-9, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16786418

RESUMO

Only a limited number of economic evaluations have addressed the costs and benefits of preconception care. In order to persuade health care providers, payers, or purchasers to become actively involved in promoting preconception care, it is important to demonstrate the value of doing so through development of a "business case". Perceived benefits in terms of organizational reputation and market share can be influential in forming a business case. In addition, it is standard to include an economic analysis of financial costs and benefits from the perspective of the provider practice, payer, or purchaser in a business case. The methods, data needs, and other issues involved with preparing an economic analysis of the likely financial return on investment in preconception care are presented here. This is accompanied by a review or case study of economic evaluations of preconception care for women with recognized diabetes. Although the data are not sufficient to draw firm conclusions, there are indications that such care may yield positive financial benefits to health care organizations through reduction in maternal and infant hospitalizations. More work is needed to establish how costs and economic benefits are distributed among different types of organizations. Also, the optimum methods of delivering preconception care for women with diabetes need to be evaluated. Similar assessments should also be conducted for other forms of preconception care, including comprehensive care.


Assuntos
Promoção da Saúde/economia , Investimentos em Saúde , Bem-Estar Materno/economia , Cuidado Pré-Concepcional/economia , Cuidado Pré-Natal/economia , Anormalidades Congênitas/economia , Análise Custo-Benefício , Feminino , Humanos , Recém-Nascido , Estudos de Casos Organizacionais , Gravidez , Gravidez em Diabéticas/economia , Avaliação de Programas e Projetos de Saúde , Tempo , Estados Unidos
5.
West J Med ; 166(5): 306-12, 1997 May.
Artigo em Inglês | MEDLINE | ID: mdl-9217432

RESUMO

This study used published relative risk estimates for birth defects, premature birth, and coronary heart disease associated with vitamin intake to project potential annual cost reductions in U.S. hospitalization charges. Epidemiological and intervention studies with relative risk estimates were identified via MEDLINE. Preventable fraction estimates were derived from data on the percentage of at-risk Americans with daily vitamin intake levels lower than those associated with disease risk reduction. Hospitalization rates were obtained from the 1992 National Hospital Discharge Survey. Charge data from the 1993 California Hospital Discharge Survey were adjusted to 1995 national charges using the medical component of the Consumer Price Index. Based on published risk reductions, annual hospital charges for birth defects, low-birth-weight premature births, and coronary heart disease could be reduced by about 40, 60, and 38%, respectively. For the conditions studied, nearly $20 billion in hospital charges were potentially avoidable with daily use of folic acid and zinc-containing multivitamins by all women of childbearing age and daily vitamin E supplementation by those over 50.


Assuntos
Redução de Custos , Alimentos Fortificados , Preços Hospitalares , Hospitalização/economia , Vitaminas/uso terapêutico , Adulto , Anormalidades Congênitas/economia , Anormalidades Congênitas/epidemiologia , Doença das Coronárias/economia , Doença das Coronárias/epidemiologia , Feminino , Ácido Fólico/uso terapêutico , Humanos , Recém-Nascido de Baixo Peso , Recém-Nascido , Pessoa de Meia-Idade , Medição de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA